Zurueck zur Suche

Reporte zur Charge UJ690AB

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

6Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NC 1 CA 1 PA 1 WA 1 TX 1 ME 1

VAERS 1777318

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ690AB

schwer
Staat
NC
Alter
73,0
Geschlecht
F
Eingang
11.10.2021
Impfdatum
07.10.2021
Beginn
07.10.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Mass Pain in extremity Peripheral swelling Superficial vein thrombosis Tenderness

Symptomtext

Developed pain and swelling in the posterior distal aspect of right upper leg several hours after receiving the vaccine. Progressively enlarged until date of evaluation on 10/11/2021. Palpable tender rope like mass with overlying erythema on posterior distal aspect of right upper leg.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Superficial vein thrombosis
Hospital-Tage
-
Labordaten
5 cm SVT in the distal greater saphenous vein without involvement of the saphenous-femoral junction
Aktuelle Erkrankungen
None reported
Vorgeschichte
Osteoporosis, depression, hypothyroidism, chronic kidney disease stage 3
Andere Medikamente
Duloxetine, levothyroxine, calcium , baby aspirin, Vitamin D
Allergien
None reported
Vorherige Impfungen
-

VAERS 2549473

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ690AB

gering
Staat
CA
Alter
70,0
Geschlecht
F
Eingang
03.01.2023
Impfdatum
03.01.2023
Beginn
03.01.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

Patient received Fluzone HD, 65yrs+, 0.7ml, IM, Once with expiration date of 6/30/2022. Patient was contacted and made aware she incorrectly received an expired vaccine. Dr. advised no adverse effects to the patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Upper respiratory tract infection, unspecified type Chronic bronchitis, unspecified chronic bronchitis type (HCC) Hypokalemia
Vorgeschichte
-
Andere Medikamente
beclomethasone dipropionate (Qvar RediHaler) 80 mcg/actuation HFA aerosol breath activated potassium chloride CR (Klor-Con M10) 10 mEq ER tablet
Allergien
NKA
Vorherige Impfungen
-

VAERS 2514964

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ690AB

gering
Staat
PA
Alter
-
Geschlecht
U
Eingang
23.11.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Medication error No adverse event

Symptomtext

office administered an expired highdose flu vaccine from 2021-2022 season (with no reported adverse event); Initial information received on 15-Nov-2022 regarding an unsolicited valid non-serious case received from a consumer/non-hcp. This case involves Adult and unknown gender patient who reported office administered an expired INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] from 2021-2022 season (with no reported adverse event). The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE Suspension for injection in pre-filled syringe (lot UJ690AB) via intramuscular route in unknown administration site for Prophylactic vaccination . On an unknown date the patient reported a non-serious event office administered an expired INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] from 2021-2022 season (with no reported adverse event) (expired product administered) (unknown latency). Action taken: not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1813540

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ690AB

gering
Staat
WA
Alter
59,0
Geschlecht
M
Eingang
23.10.2021
Impfdatum
21.10.2021
Beginn
21.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Interchange of vaccine products

Symptomtext

Inadvertent administration of incorrect maker of Covid-19 vaccine #2 with Pfizer. Patient received Moderna Covid-19 vaccine #1 three weeks prior and was due to have Moderna for 2nd dose, not Pfizer.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Interchange of vaccine products
Hospital-Tage
-
Labordaten
None thus far. There is a plan to check basic metabolic panel in near future.
Aktuelle Erkrankungen
-
Vorgeschichte
hypertension, early onset Alzheimer's disease, moderately advanced dementia, chronic kidney disease
Andere Medikamente
lisinopril, memantine, Vitamin D, lorazepam
Allergien
tomatoes, oranges
Vorherige Impfungen
-

VAERS 1813064

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ690AB

gering
Staat
TX
Alter
54,0
Geschlecht
F
Eingang
23.10.2021
Impfdatum
28.09.2021
Beginn
28.09.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age Wrong product administered

Symptomtext

female patient age 54 was given FLUZONE HIGH DOSE with no reported adverse event; female patient inadvertently was administered Fluzone High-Dose Quadrivalent vaccine rather than Fluzone Quadrivalent vaccine with no reported adverse event; Initial information received on 13-Oct-2021 regarding an unsolicited valid non-serious case from other health professional and physician via Agency(under reference 00810932). This case involves a 54 years old female patient who inadvertently was administered INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT] rather than INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] (product administered to patient of inappropriate age and wrong product administered). The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient received no concomitant vaccines. On 28-Sep-2021, the patient received a 0.7 mL dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot UJ690AB and expiration date: 30-Jun-2022) via unknown route in the arm for prophylactic vaccination. It was an actual medication error due to inappropriate age at vaccine administration and wrong vaccine administered (same day latency). It was reported "Caller states on 28SEP2021, a female patient age 54 was given FLUZONE HIGH DOSE; caller would like to report the incident and obtain information regarding re-vaccination and adverse effects to look out for; caller asked for any efficacy and safety information on Fluzone High-Dose administered to patients younger than 65 years of age, and any comparison information on the Fluzone High-Dose and Fluzone vaccines. Reporter was unsure whether it was administered in the left arm or right arm." At time of reporting, no adverse event reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1784630

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ690AB

gering
Staat
ME
Alter
53,0
Geschlecht
M
Eingang
14.10.2021
Impfdatum
13.10.2021
Beginn
13.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered Product administered to patient of inappropriate age Wrong product administered

Symptomtext

Resident received high dose vaccine but should have received regular dose vaccine based on his age.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
n/a
Vorgeschichte
2/16/2020 G82.51 QUADRIPLEGIA, C1-C4 COMPLETE 11/1/2020 R44.1 VISUAL HALLUCINATIONS 11/1/2020 S06.899S INTCRAN INJ W LOC OF UNSP DURATION, SEQUELA 11/1/2020 B95.62 METHICILLIN RESIS STAPH INFCT CAUSING DISEASES CLASSD ELSWHR 11/1/2020 Z22.322 CARRIER OR SUSPECTED CARRIER OF METHICILLIN RESIS STAPH 11/1/2020 Z22.39 CARRIER OF OTHER SPECIFIED BACTERIAL DISEASES 2/16/2020 F28 OTH PSYCH DISORDER NOT DUE TO A SUB OR KNOWN PHYSIOL COND 2/16/2020 E11.9 TYPE 2 DIABETES MELLITUS WITHOUT COMPLICATIONS 2/16/2020 F41.9 ANXIETY DISORDER, UNSPECIFIED 2/16/2020 N31.9 NEUROMUSCULAR DYSFUNCTION OF BLADDER, UNSPECIFIED 2/16/2020 W86.8XXS EXPOSURE TO OTHER ELECTRIC CURRENT, SEQUELA 2/16/2020 F32.9 MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, UNSPECIFIED 2/16/2020 M62.838 OTHER MUSCLE SPASM 2/16/2020 G47.36 SLEEP RELATED HYPOVENTILATION IN CONDITIONS CLASSD ELSWHR 2/16/2020 H18.40 UNSPECIFIED CORNEAL DEGENERATION 2/16/2020 Z87.440 PERSONAL HISTORY OF URINARY (TRACT) INFECTIONS
Andere Medikamente
carBAMazepine Tablet Refresh Tears Solution (Carboxymethylcellulose Sodium) Active 9/5/2021 9/5/2021 Tylenol Tablet (Acetaminophen) traZODone HCl Tablet 50 MG Pepcid Tablet (Famotidine) Alphagan P Solution (Brimonidine Tartrate)
Allergien
Baclofen, Demerol, Flexeril, Neurontin, Tegaderm Absorbent Dressing
Vorherige Impfungen
-